Cosentyx
The Top Pharma List rankings are compiled from GlobalData’s pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. Listed below are the charts and positions for Cosentyx in this year’s pharmaceutical sales data alongside recent articles on PMLiVE featuring Cosentyx.
27
Global Revenue Ranking
33
2030 Global forecast Ranking
Recent articles on PMLiVE featuring Cosentyx
The REPLENISH trial met all primary and secondary endpoints, demonstrating sustained remission vs placebo
The rare blood disease is estimated to affect only ten to 20 people per million worldwide
The decision makes Cosentyx the first biologic treatment approved for HS in nearly a decade
At least 200,000 people in the UK are affected by the inflammatory skin disease
There are around 200,000 people in Europe living with moderate to severe stages of HS
An estimated one in 100 people globally are affected by the inflammatory skin disease
An estimated one in 100 people globally are affected by the inflammatory skin disease
A phase 3 trial showed significantly longer time to flare for both JPsA and ERA patients
The company has started a strategic review of Sandoz as sales drop 20% in ‘challenging’ US market
Swiss pharma company also provided key updates on a number of drug candidates in its pipeline
Sales grew in the quarter but profits fell short of forecasts
Core operating income increased by 11%, profits from net income drop
Data provided by GlobalData
GlobalData provides trusted intelligence on the world’s largest industries including Pharmaceutical and Medical Devices. With over 2,000 in-house experts, our data-driven, technology-powered approach delivers gold-standard insights to help businesses navigate complex markets and predict future trends.
Our integrated platform empowers 4,000 of the world’s largest companies—including over 70% of FTSE 100 and 60% of Fortune 100 firms—to make timely, informed decisions through unique data, expert analysis, and innovative consulting solutions.
To find out more about how our research and insights can help you, please visit https://www.globaldata.com/who-we-are/why-globaldata/
For more details on the data and methodology used to create the Top Pharma Lists, please visit PMLiVE’s Top Pharma List – Methodology